By Euro Weekly News Media • Published: 11 Nov 2012 • 17:00
LMTX could offer hope for millions of Alzheimer’s sufferers
A NEW pill that is said to halt the devastating onset of Alzheimer’s disease could be on the market within four years.
Currently known as LMTX, it is thought to be twice as good as anything already available and could greatly slow, and possibly even halt, the onset of the disease.
The pill – developed by British scientists – has already been tested on patients, with ‘unprecedented’ results according to its inventor, Professor Claude Wischik who said, “It flat lines the disease. If you get in early, you can pull people back from the brink.”
Meanwhile, scientists are also looking at the link between Alzheimer’s and type 2 diabetes – caused by eating too much junk food. The new theory has led to hope that treatments for diabetes may also help dementia sufferers.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.